Lifevantage (NASDAQ:LFVN) Stock Crosses Below 200 Day Moving Average – Should You Sell?

Lifevantage Corporation (NASDAQ:LFVN)’s stock price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $6.50 and traded as low as $4.17. Lifevantage shares last traded at $4.18, with a volume of 72,319 shares changing hands.

Analyst Upgrades and Downgrades

LFVN has been the subject of several analyst reports. Loop Capital set a $5.00 price target on shares of Lifevantage in a report on Thursday, February 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Lifevantage in a research report on Friday, March 27th. Finally, Lake Street Capital reiterated a “buy” rating on shares of Lifevantage in a research report on Thursday, February 5th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $5.00.

Lifevantage Stock Performance

The company’s 50-day moving average price is $4.85 and its two-hundred day moving average price is $6.50. The stock has a market cap of $53.55 million, a PE ratio of 6.97 and a beta of 0.36.

Lifevantage (NASDAQ:LFVN) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.07). The company had revenue of $48.93 million for the quarter, compared to analysts’ expectations of $54.40 million. Lifevantage had a net margin of 3.74% and a return on equity of 29.59%. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.

Lifevantage Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were given a dividend of $0.045 per share. The ex-dividend date was Monday, March 2nd. This represents a $0.18 annualized dividend and a dividend yield of 4.3%. Lifevantage’s dividend payout ratio (DPR) is 30.00%.

Insider Buying and Selling

In other Lifevantage news, Director Judd Dayton purchased 18,097 shares of the stock in a transaction on Friday, February 27th. The stock was acquired at an average cost of $4.63 per share, with a total value of $83,789.11. Following the completion of the purchase, the director directly owned 69,859 shares of the company’s stock, valued at approximately $323,447.17. This trade represents a 34.96% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. In the last 90 days, insiders have acquired 38,207 shares of company stock valued at $178,585. 21.95% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Jane Street Group LLC grew its stake in shares of Lifevantage by 5.4% during the first quarter. Jane Street Group LLC now owns 36,567 shares of the company’s stock valued at $533,000 after buying an additional 1,877 shares during the last quarter. Cetera Investment Advisers grew its stake in shares of Lifevantage by 10.8% during the second quarter. Cetera Investment Advisers now owns 20,098 shares of the company’s stock valued at $263,000 after buying an additional 1,954 shares during the last quarter. Invesco Ltd. grew its stake in shares of Lifevantage by 13.6% during the fourth quarter. Invesco Ltd. now owns 30,085 shares of the company’s stock valued at $185,000 after buying an additional 3,603 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Lifevantage by 870.2% during the second quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company’s stock valued at $66,000 after buying an additional 4,499 shares during the last quarter. Finally, LPL Financial LLC grew its stake in shares of Lifevantage by 19.0% during the fourth quarter. LPL Financial LLC now owns 28,303 shares of the company’s stock valued at $174,000 after buying an additional 4,524 shares during the last quarter. 35.32% of the stock is owned by institutional investors.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.